クローニングと変異導入の世界市場規模調査＆予測、製品別、技術別、エンドユーザー別、地域別分析、2022-2029年

世界のクローニングと変異導入市場は、2021年に約20億米ドルと評価され、予測期間2022-2029年には18.7%以上の健全な成長率で成長すると予測されています。

クローニングとは、自然発生的または人工的に作られた、遺伝子的に同一の生物のコピーを作成するプロセスです。変異原性とは、生物の遺伝的組成が変化し、突然変異を引き起こすプロセスです。実験室では、DNAを意図的に改変し、変異タンパク質、遺伝子、または生物の株を作製することで変異誘発が行われます。クローニングと変異導入は、タンパク質の構造と機能の関連性を研究するために生まれた最も効果的な方法の2つです。クローニングと変異導入は、タンパク質の構造と機能の関連性を研究するために生まれた最も効果的な方法であり、in vitroとin vivoの両方で突然変異の影響を確認するために使用されます。生殖クローンなど、数多くの遺伝学的応用におけるクローニングの使用が増加しているため、世界のクローニングおよび突然変異誘発産業は上昇すると予想されています。遺伝性疾患や慢性疾患の有病率は増加し、個別化医療に対する需要も増加すると予想されます。遺伝的問題や、がんやHIVなどの病気の治癒を目的とした研究開発のための資金調達が増加しているため、クローニングおよび突然変異誘発技術の必要性はますます高まってきています。

世界市場を牽引する主な要因は、遺伝性疾患や慢性疾患の有病率の上昇、個別化医療に対する需要の高まり、新規参入企業の増加です。業界の拡大は、遺伝子合成およびクローニングサービスに対する有利な資金調達条件、クローニング業界の技術的進歩、うまく連携する商業活動の増加によってさらに助長されます。革新的で効果的なDNAおよび遺伝子クローニングサービスは、業界のトップ企業によって開発されています。statistaによると、2019年に全世界で約1,790万人があらゆる種類の心血管障害の結果、亡くなりました。いくつかの慢性疾患に起因する2019年の世界の死亡者数は、このデータに示されています。慢性疾患は、人々のQOLや寿命だけでなく、世界中の社会や政府にも悪影響を及ぼします。研究開発の充実は、多くの可能性を広げることができます。しかし、クローンや突然変異の副作用が、2022-2029年の予測期間における市場成長を制限しています。

クローニングと変異導入の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は収益面で市場を独占しており、また、ゲノムおよびプロテオミクスデータを基に構築されたプラットフォームがより広く受け入れられるにつれ、クローニングおよび突然変異誘発法がこの地域でより頻繁に使用されています。この地域でのより大きな製品浸透は、トップ発明者と市場プレイヤーの存在に起因しています。2021年5月、米国のTelesis Bio, Inc.は、例えば、同社のBioXp技術が長大なフラグメントクローニングを提供するようになったと発表しました。このプロジェクトの助けを借りて、研究者は一晩でカスタムベクターにハンドフリークローニングし、多変量でエラー訂正されたベクターを生産することができます。

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • クローニングと変異導入市場、地域別、2019-2029年
  • クローニングと変異導入市場、製品別、2019-2029年
  • クローニングと変異導入市場、技術別、2019-2029年
  • クローニングと変異導入市場、エンドユーザー別、2019-2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 世界のクローニングと変異導入市場の定義とスコープ

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 世界のクローニングと変異導入市場力学

• クローニングと変異導入市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 高まるオーダーメイド医療へのニーズ
    • 遺伝性疾患や慢性疾患の頻度上昇
    • 新規参入事業者の増加
  • 市場の課題
    • 遺伝的疾患やがんの原因となる悪影響により、市場の成長は抑制されています
  • 市場の可能性
    • 研究開発の増加
    • 製剤に向けた高い開発力と最近の進歩

第4章 世界のクローニングと変異導入市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 最高の投資機会
• 主要成功戦略
• 業界関係者見通し
• アナリストの提言と結論

第5章 リスクアセスメントCOVID-19の衝撃

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 クローニングと変異導入の世界市場：製品別

• マーケットスナップショット
• クローニングと変異導入の世界市場：製品別、性能別- ポテンシャル分析
• クローニングと変異導入の世界市場製品別推定・予測2019-2029
• クローニングと変異導入市場、サブセグメント分析
  • クローニングキット
  • ミュータジェネシスキット

第7章 クローニングと変異導入の世界市場：技術別

• マーケットスナップショット
• クローニングと変異導入の世界市場：技術別、パフォーマンス別- ポテンシャル分析
• 世界のクローニングと変異導入市場の技術別推定・予測2019-2029
• クローニングと変異導入市場、サブセグメント分析
  • Topo PCRクローニング
  • ブラントエンドクローニング
  • シームレスクローニング
  • サイトディレクションクローニング
  • その他

第8章 クローニングと変異導入の世界市場：エンドユーザー別

• マーケットスナップショット
• クローニングと変異導入の世界市場：エンドユーザー別、パフォーマンス-ポテンシャル分析
• クローニングと変異導入の世界市場エンドユーザー別推定・予測2019-2029
• クローニングと変異導入市場、サブセグメント分析
  • バイオ医薬品・製薬会社
  • CRO・CMO
  • 学術・研究機関など

第9章 クローニングと変異導入の世界市場：地域別分析

• クローニングと変異導入市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品別の推定・予測、2019年～2029年
    • 技術別の推定・予測、2019年～2029年
    • エンドユーザー別の推定・予測、2019年～2029年
  • カナダ
• 欧州クローニングと変異導入市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋のクローニングと変異導入市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのクローニングと変異導入市場のスナップショット
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域
• 世界のその他の地域

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Agilent Technologies, Inc
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Agilent Technologies, Inc
  • New England Biolabs Inc.
  • Takara Bio Inc.
  • Merck KGaA
  • Promega Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Jena Bioscience GmbH
  • Assay Genie

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Cloning and Mutagenesis Market, report scope
• TABLE 2. Global Cloning and Mutagenesis Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Cloning and Mutagenesis Market estimates & forecasts by Product 2019-2029 (USD Billion)
• TABLE 4. Global Cloning and Mutagenesis Market estimates & forecasts by Technology 2019-2029 (USD Billion)
• TABLE 5. Global Cloning and Mutagenesis Market estimates & forecasts by End user 2019-2029 (USD Billion)
• TABLE 6. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Cloning and Mutagenesis Market
• TABLE 71. List of primary sources, used in the study of global Cloning and Mutagenesis Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Cloning and Mutagenesis Market, research methodology
• FIG 2. Global Cloning and Mutagenesis Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Cloning and Mutagenesis Market, key trends 2021
• FIG 5. Global Cloning and Mutagenesis Market, growth prospects 2022-2029
• FIG 6. Global Cloning and Mutagenesis Market, porters 5 force model
• FIG 7. Global Cloning and Mutagenesis Market, pest analysis
• FIG 8. Global Cloning and Mutagenesis Market, value chain analysis
• FIG 9. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Cloning and Mutagenesis Market, regional snapshot 2019 & 2029
• FIG 15. North America Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
• FIG 17. Asia Pacific Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
• FIG 19. Global Cloning and Mutagenesis Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Cloning and Mutagenesis Market is valued at approximately USD 2.00 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.7% over the forecast period 2022-2029. Cloning is the process of creating naturally occurring or artificially produced, genetically identical copies of an organism. Mutagenesis is the process through which an organism's genetic composition is altered, leading to a mutation. In a laboratory context, mutagenesis is carried out when DNA is intentionally modified to produce mutant proteins, genes, or strains of an organism. Cloning and mutagenesis are two of the most effective methods created to research the links between protein structure and function. They are used to confirm the effects of mutations both in vitro and in vivo. Due to the growing use of cloning in numerous genetic applications, such as reproductive cloning, the global cloning and mutagenesis industry is expected to rise. The prevalence of hereditary and chronic diseases is expected to increase, as is the demand for personalized medicine. Due to growing financing for research and development targeted at curing genetic issues and other diseases, such as cancer and HIV, cloning and mutagenesis technologies are becoming more and more necessary.

The primary factors driving the global market are the rise in the prevalence of hereditary and chronic diseases, the rise in demand for personalized medicine, and the rise in new companies entering the industry. The industry's expansion is further aided by favorable funding conditions for gene synthesis and cloning services, technological advancements in the cloning industry, and an increase in commercial activities that work together well. Innovative, effective DNA and gene cloning services are being developed by top industry players. According to statista, nearly 17.9 million people worldwide passed away in 2019 as a result of cardiovascular disorders of all kinds. The number of deaths worldwide in 2019 attributable to a few chronic diseases is shown in this data. Chronic illness has negative effects on people's quality of life and lifespan, as well as on society and governments around the world. An enhancement in research and development can open up many opportunities. However, the side effects of cloning and mutation are restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Cloning and Mutagenesis Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, additionally, Cloning and mutagenesis methods are now used more frequently in the region as platforms built on genomic and proteomic data become more widely accepted. Greater product penetration in the region is due to the presence of top inventors and market players. In May 2021, Telesis Bio, Inc., a U.S. company, announced, for instance, that its BioXp technology now offers lengthy fragment cloning. With the help of this project, researchers may overnight hand-free clone into custom vectors and produce multivariant, error-corrected vectors.

Major market players included in this report are:

• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• New England Biolabs Inc.
• Takara Bio Inc.
• Merck KGaA
• Promega Corporation
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Jena Bioscience GmbH
• Assay Genie

Recent Developments in the Market:

• In May 2021, the American company Telesis Bio, Inc. announced long fragment cloning is now supported by its BioXp technology. This project enables researchers to build multivariant, error-corrected vectors and hand-free overnight clone them into custom vectors.
• In June 2019, The Human Glycome Project, a global endeavour to map the composition and function of human glycans, was announced by NEB, Waters, and Genos as a collaboration. To help with better sample preparation and process throughput, NEB will provide a variant of their Rapid PNGase F technology. In order to give its consumers access to illustrations of how its products are used in actual situations, NEB partnered with the artificial intelligence technology firm Bioz, Inc. in the same month.

Global Cloning and Mutagenesis Market Report Scope:

• Historical Data 2019-2020-2021

• Base Year for Estimation 2021

• Forecast period 2022-2029

• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered Product, Technology, End User, Region

• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Cloning Kits
• Mutagenesis Kits

By Technology:

• Topo PCR Cloning
• Blunt End Cloning
• Seamless Cloning
• Site-directed Mutagenesis
• Others

By End User:

• Biopharmaceutical & Pharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• ROLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Cloning and Mutagenesis Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Cloning and Mutagenesis Market, by Product, 2019-2029 (USD Billion)
  • 1.2.3. Cloning and Mutagenesis Market, by Technology, 2019-2029 (USD Billion)
  • 1.2.4. Cloning and Mutagenesis Market, by End User, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Cloning and Mutagenesis Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Cloning and Mutagenesis Market Dynamics

• 3.1. Cloning and Mutagenesis Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing need for customised medicine
    • 3.1.1.2. rise in the frequency of inherited and chronic illnesses
    • 3.1.1.3. the growth in new businesses entering the market
  • 3.1.2. Market Challenges
    • 3.1.2.1 The market growth is being constrained by the negative consequences of causing genetic disorder or cancer.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increase in research & development
    • 3.1.3.2. Higher developments and recent advancements towards the formulation.

Chapter 4. Global Cloning and Mutagenesis Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cloning and Mutagenesis Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Cloning and Mutagenesis Market by Product ,Performance - Potential Analysis
• 6.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by Product2019-2029 (USD Billion)
• 6.4. Cloning and Mutagenesis Market, Sub Segment Analysis
  • 6.4.1. Cloning kits
  • 6.4.2. Mutagenesis kits

Chapter 7. Global Cloning and Mutagenesis Market, by Technology

• 7.1. Market Snapshot
• 7.2. Global Cloning and Mutagenesis Market by Technology, Performance - Potential Analysis
• 7.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
• 7.4. Cloning and Mutagenesis Market, Sub Segment Analysis
  • 7.4.1. Topo PCR Cloning
  • 7.4.2. Blunt End Cloning
  • 7.4.3. Seamless Cloning
  • 7.4.4. Site directed Cloning
  • 7.4.5. Others

Chapter 8. Global Cloning and Mutagenesis Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Cloning and Mutagenesis Market by End user, Performance - Potential Analysis
• 8.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by End user 2019-2029 (USD Billion)
• 8.4. Cloning and Mutagenesis Market, Sub Segment Analysis
  • 8.4.1. Biopharmaceutical & Pharmaceutical companies
  • 8.4.2. CROs & CMOs
  • 8.4.3. Academic & Research Institutes

Chapter 9. Global Cloning and Mutagenesis Market, Regional Analysis

• 9.1. Cloning and Mutagenesis Market, Regional Market Snapshot
• 9.2. North America Cloning and Mutagenesis Market
  • 9.2.1. U.S. Cloning and Mutagenesis Market
    • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End user breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Cloning and Mutagenesis Market
• 9.3. Europe Cloning and Mutagenesis Market Snapshot
  • 9.3.1. U.K. Cloning and Mutagenesis Market
  • 9.3.2. Germany Cloning and Mutagenesis Market
  • 9.3.3. France Cloning and Mutagenesis Market
  • 9.3.4. Spain Cloning and Mutagenesis Market
  • 9.3.5. Italy Cloning and Mutagenesis Market
  • 9.3.6. Rest of Europe Cloning and Mutagenesis Market
• 9.4. Asia-Pacific Cloning and Mutagenesis Market Snapshot
  • 9.4.1. China Cloning and Mutagenesis Market
  • 9.4.2. India Cloning and Mutagenesis Market
  • 9.4.3. Japan Cloning and Mutagenesis Market
  • 9.4.4. Australia Cloning and Mutagenesis Market
  • 9.4.5. South Korea Cloning and Mutagenesis Market
  • 9.4.6. Rest of Asia Pacific Cloning and Mutagenesis Market
• 9.5. Latin America Cloning and Mutagenesis Market Snapshot
  • 9.5.1. Brazil Cloning and Mutagenesis Market
  • 9.5.2. Mexico Cloning and Mutagenesis Market
  • 9.5.3. Rest of Latin America Cloning and Mutagenesis Market
• 9.6. Rest of The World Cloning and Mutagenesis Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Agilent Technologies, Inc
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Agilent Technologies, Inc
  • 10.2.3. New England Biolabs Inc.
  • 10.2.4. Takara Bio Inc.
  • 10.2.5. Merck KGaA
  • 10.2.6. Promega Corporation
  • 10.2.7. Bio-Rad Laboratories Inc.
  • 10.2.8. Danaher Corporation
  • 10.2.9. Jena Bioscience GmbH
  • 10.2.10. Assay Genie

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption